Blueprint
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of Report (Date of earliest event reported): January
31, 2019
WOUND
MANAGEMENT TECHNOLOGIES, INC.
(Exact
name of registrant as specified in its charter)
|
Texas
|
|
000-11808
|
|
59-2219994
|
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification No.)
|
|
1200 Summit
Avenue, Suite 414
Fort Worth,
Texas
|
|
76102
|
|
(Address
of principal executive offices)
|
|
(zip
code)
|
Registrant’s
telephone number, including area code: (817)-529-2300
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Indicate by check
mark whether the registrant is an emerging growth company as
defined in in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§240.12b-2 of this chapter).
Emerging growth
company ☐
If an emerging
growth company, indicate by checkmark if the registrant has elected
not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
Effective
January 31, 2019, John Siedhoff resigned as Chairman and member of
the Board of Directors of Wound Management Technologies, Inc. (the
“Company”). Mr. Siedhoff did not resign as a result of
a disagreement with the Company.
Mr.
Jim Stuckert, a Company Board member since 2015 and retired
Chairman and Chief Executive Officer of J.J.B. Hilliard, W.L.
Lyons, LLC, assumed the role of Chairman effective February 1,
2019.
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Company
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
WOUND
MANAGEMENT TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
Date: February 06,
2019
|
By:
|
/s/ Michael
McNeil
|
|
|
|
Name:
|
Michael
McNeil
|
|
|
|
Title:
|
Chief Financial
Officer
|
|